Molecular models for pharmacological tolerance and addiction.
D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002460:Cell Line / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development; D004361:Drug Tolerance; D004789:Enzyme Activation; D005826:Genetics, Medical; D006321:Heart / Q000187:drug effects; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000201:enzymology; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D008954:Models, Biological; D009132:Muscles / Q000187:drug effects / Q000201:enzymology; D009154:Mutation; D009206:Myocardium / Q000201:enzymology; D009711:Nucleotides / Q000494:pharmacology; D009963:Orotic Acid; D051381:Rats; D013154:Spleen / Q000187:drug effects / Q000201:enzymology; D019966:Substance-Related Disorders; D014498:Uracil / Q000031:analogs & derivatives / Q000494:pharmacology; D014500:Uracil Nucleotides / Q000096:biosynthesis
D001463:Barbiturates; D009711:Nucleotides; D014500:Uracil Nucleotides; D014498:Uracil; D009963:Orotic Acid; D002262:Carboxy-Lyases